BlackRock, Inc. 13D and 13G filings for Sarepta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-07 1:30 pm Purchase |
2024-05-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
BlackRock Inc. BLK |
10,124,431 10.700% |
3,857,458 (+61.55%) |
Filing |
| 2024-01-26 5:26 pm Purchase |
2023-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
BlackRock Inc. BLK |
6,266,973 6.700% |
709,739 (+12.77%) |
Filing |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
BlackRock Inc. BLK |
5,557,234 6.300% |
272,000 (+5.15%) |
Filing |
| 2022-02-01 5:14 pm Sale |
2021-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
BlackRock Inc. BLK |
5,285,234 6.100% |
-93,981 (-1.75%) |
Filing |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
BlackRock Inc. BLK |
5,379,215 6.800% |
738,930 (+15.92%) |
Filing |